1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Patient Monitoring Market Trends
  5. > Neuromodulation Devices Global Market – Forecast To 2021

Neuromodulation Devices Global Market – Forecast To 2021

  • December 2015
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 256 pages


Table of Contents

Search Inside


The neuromodulation technology utilizes devices that bring about a change in nervous system either by stimulation or modulating brain activity. The treatment delivered by neuromodulation devices brings about life changing transformation in patients who fail to get better by traditional approaches. The opportunities to development new therapies for a wide variety of neurological and psychological conditions are attracting lot of companies, start ups and investments. According to IQ4I analysis, the global neuromodulation devices market is expected to grow at a double digit CAGR to reach $9.3 billion by 2021.

Factors driving the neuromodulation market include, projected increase in patients with chronic pain, neurodegenerative diseases, psychiatric conditions, improvements in technology such as miniaturization, better battery technology, use of bioactive coatings are all contributing for growth of neuromodulation devices market whereas risk of side effects, availability of alternative treatment and high initial cost of implants are the factors hampering the market growth. Advancement of technology with its wide application areas shows that neuromodulation devices market has vast opportunities in the coming years.

Neuromodulation devices market is segmented on the basis of technology as internal and external neuromodulation. The internal neuromodulation is again classified into Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS) and Other with Gastric Electric Stimulation (GES) and Respiratory Electrical Stimulation (RES)/Phrenic Nerve Stimulation (PNS). Based on the application the neuromodulation devices market is segmented into Chronic Pain, Movement Disorders, Psychiatric Conditions, Gastroenterology & Urology and other applications. Based on end-users the market is segmented into hospitals and private neuromodulation clinics.

North America accounts for the highest market share of 56.1% followed by Europe. Steep rise in ageing population, advancement in technology, awareness of people and favourable government policies makes U.S. the leader of neuromodulation devices market. However, Asian countries especially India and China are the fast growing regions with its growing demand for neuromodulation devices.

Major players in Neuromodulation devices market include Medtronic (Ireland), Boston Scientific (U.S.), Cyberonics (U.S.), St. Jude Medical (U.S.), Neurometrix, Inc (U.S.), Neuronetics, Inc (U.S.), Nevro Corporation (U.S.), Synapse Biomedical (U.S.), Avery Biomedical (U.S.) and Magstim (U.K.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Europe Market for Neuromodulation Devices 2017 - MedCore

Europe Market for Neuromodulation Devices 2017 - MedCore

  • $ 4995
  • Industry report
  • December 2016
  • by iData Research, Inc.

Neuromodulation devices are used for regulating the nervous system, either to correct an abnormality in the system or to treat a condition. The devices consist of a pulse generator, leads and electrodes. ...

US Market Report for Neuromodulation Devices 2017 - MedCore

US Market Report for Neuromodulation Devices 2017 - MedCore

  • $ 5495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description Market growth will be propelled by wider acceptance of neuromodulation products, allowing them to be used on a larger proportion of potential patients. In addition, many neuromodulation patients ...

BRIC Glucose Monitoring Market Outlook to 2022

BRIC Glucose Monitoring Market Outlook to 2022

  • $ 5995
  • Industry report
  • January 2017
  • by GlobalData

BRIC Glucose Monitoring Market Outlook to 2022 Summary GlobalData’s new report, "BRIC Glucose Monitoring Market Outlook to 2022", provides key market data on the BRIC Glucose Monitoring market. The report ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.